Bone metabolism and clinical study of 44 patients with bisphosphonate-related osteonecrosis of the jaws [PDF]
, 2012 Osteonecrosis of the jaws is a clinical entity described and linked to treatment with bisphosphonates in 2003. Its real incidence is unknown and it could increase due to the large number of patients treated with these drugs, and its cumulative effect on ...
Bocanegra Pérez, Sacramento +7 more
core +1 more source
Imaging Findings of Bisphosphonate-Associated Osteonecrosis of the Jaws [PDF]
American Journal of Neuroradiology, 2007 Bisphosphonates are drugs that decrease bone turnover by inhibiting osteoclast activity. An association between the use of bisphosphonates and osteonecrosis of the maxilla and mandible has recently been described. This study describes the imaging findings of bisphosphonate-associated osteonecrosis of the jaws.This is a retrospective series of 15 ...
P M, Phal +3 more
openaire +2 more sources
A Case Report of Ibandronic Acid Induced Non-Exposed BRONJ Involving the Maxillary Sinus
eJournal of Oral Maxillofacial Research, 2023 Background: The aim of this case report is to present an interesting case of bisphosphonate-related osteonecrosis of the jaw, involving the maxilla and the maxillary sinus, as a result of per os administration of ibandronic acid.
Ioannis Fotopoulos +6 more
doaj +1 more source
Alternative treatments for oral bisphosphonate-related osteonecrosis of the jaws: a pilot study comparing fibrin rich in growth factors and teriparatide [PDF]
, 2014 Objectives: The aim of this study is to describe and compare the evolution of recurrent bisphosphonate-related osteonecrosis of the jaws (BRONJ) in patients treated with plasma rich in growth factors or teriparatide.
Gallego, Lorena +5 more
core +1 more source
Dental complications and management of patients on bisphosphonate therapy: A review article
Journal of Oral Biology and Craniofacial Research, 2013 Bisphosphonates are group of drugs that inhibit bone resorption and are used to treat a range of pathologies including Paget's disease, osteoporosis, multiple myeloma and metastasis associated with breast or prostate cancer.
Sandeep Kalra, Veena Jain
doaj +1 more source
Prophylaxis and antibiotic therapy in management protocols of patients treated with oral and intravenous bisphosphonates [PDF]
, 2017 Osteonecrosis of the jaw (MRONJ) linked to bisphosphonate treatment has specific characteristics that render its therapeutic management challenging for clinicians.
Bermúdez Bejarano, Elena Beatriz +6 more
core +1 more source
Bisphosphonate-related osteonecrosis of the jaw: An enigma among medical practitioners
Indian Journal of Medical and Paediatric Oncology, 2019 Context: Owing to the increasing number of cancer cases, and introduction of newer drugs like bisphosphonates (BP) for the management of metastatic bone disease, complications such as bisphosphonate-related osteonecrosis of the jaw (BRONJ) have come into
Shalini Krishnan +4 more
doaj +1 more source
Bisphosphonate-related osteonecrosis of the jaws (Bronj) [PDF]
, 2013 Bisphosphonate-related osteonecrosis of the jaws (BRONJ) is an extremely therapy resistant osteomyelitis-like disease exclusively involving the jaw bones of patients in treatment with bisphosphonates (BPs).
Beninatio, Francesco +2 more
core +1 more source
A maxillary reconstruction after osteonecrosis with surgical biomodels: A case report
Advances in Oral and Maxillofacial Surgery, 2021 Medication-related osteonecrosis of the jaw is a low prevalence condition in cancer patients which is mainly associated with bisphosphonates and other medication therapies, such as antiresorptive and antiangiogenic therapies.
Helena Polmann +3 more
doaj +1 more source